PECA Labs has added Jeffrey P Carpenter, Jeffrey O’Donnell Sr and Samuel E Navarro to its board of directors. The new board members will help guide the company as it develops and commercialises cardiovascular implants based on its novel tunable polymeric material platform.
Jeffrey P Carpenter, a vascular and endovascular surgeon, is chairman and chief of the Department of Surgery at Cooper University Healthcare in the greater Philadelphia area. In practice for 37 years, he is a founder of Embrella Cardiovascular, which was acquired by Edwards Lifesciences.
Jeffery O’Donnell Sr brings more than 25 years of board and chief executive experience at emerging medical device companies. He currently serves as managing director for medtech accelerator Runway Healthcare and as managing partner at Lucius Partners.
Samuel E Navarro is an executive with decades of experience in finance, with an emphasis in healthcare. He is currently managing partner at Gravitas Healthcare, a strategic advisory firm focused on the emerging medical device industry.
“PECA Labs’ unique polymeric material opens up an exciting and large opportunity to create and transform how cardiovascular devices, such as vascular grafts and heart valves, result in better fit and more durable implants,” said Navarro. “I believe PECA is on the verge of important inflection points in clinical, regulatory, and early commercialization progress, resulting in a very attractive opportunity for value creation.”
“We are grateful to bring on such an accomplished group of new board members, each of whom has incredible experience to offer PECA Labs,” said CEO Doug Bernstein. “With their guidance, we aim to transform the field of vascular implants to drive significantly better outcomes for physicians and their patients.”
Last month, PECA Labs announced the successful first-in-human implant of the MASA valve, a polymeric valved conduit for pulmonary valve reconstruction in paediatric patients.
